Finance

Beta
Lists
XTLB:NASDAQ
X T L Biopharmaceuticals Ltd
$2.44
-0.81%
(-0.020) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XTLB...
Open
$2.49
High
$2.49
Low
$2.39
Mkt. cap
5.98M
Avg. vol.
3.96M
Volume
9.36K
52-wk high
$10.28
52-wk low
$2.12
EPS
-$11.68
Beta
1.26
Shares outstanding
2.37M
No. of employees
10
Open
$2.49
High
$2.49
Low
$2.39
Mkt. cap
5.98M
Avg. vol.
3.96M
Volume
9.36K
52-wk high
$10.28
52-wk low
$2.12
EPS
-$11.68
Beta
1.26
Shares outstanding
2.37M
No. of employees
10
News stories
From sources across the web
About X T L Biopharmaceuticals Ltd
CEO-
Employees10
Founded1993
HeadquartersHerzliya, Tel Aviv District, Israel
SectorBiotechnology
Websitextlbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
46.00K
405.00K
258.50K
258.50K
Cost of goods sold
-
448.00K
1.39M
1.39M
Cost of revenue
-
448.00K
1.39M
1.39M
Research and development expenses
54.00K
32.00K
10.50K
10.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
756.00K
737.00K
956.00K
956.00K
Operating expense
810.00K
769.00K
1.08M
1.08M
Total operating expenses
810.00K
1.22M
2.46M
2.46M
Operating income
-764.00K
-812.00K
-2.21M
-2.21M
Other non operating income
13.00K
-90.00K
500.00
500.00
EBT including unusual items
-553.00K
-385.00K
-2.86M
-2.86M
EBT excluding unusual items
-844.00K
-800.00K
-2.23M
-2.23M
Income tax expense
-
-130.00K
-109.50K
-109.50K
Effective tax rate
-
33.77%
3.83%
3.83%
Other operating expenses
-
-
111.50K
111.50K
Net income
-553.00K
-255.00K
-2.75M
-2.75M
Net profit margin
-1,202.17%
-62.96%
-1,063.83%
-1,063.83%
Earnings per share
-
-
-
-
Interest and investment income
-
128.00K
-
-
Interest expense
-93.00K
-
-25.50K
-25.50K
Net interest expenses
-93.00K
128.00K
-25.50K
-25.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-762.25K
-2.16M
-2.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer